World’s largest battery maker announces major breakthrough in energy density
“The launch of condensed batteries will usher in an era of universal electrification of sea, land and air transportation…,” according to Chinese battery manufacturer CATL.
This archive covers technology and innovation breakthroughs that improve lives, protect the environment, and expand human possibility. From medical devices to clean energy tools, the stories here focus on what’s working and who’s making it happen.
“The launch of condensed batteries will usher in an era of universal electrification of sea, land and air transportation…,” according to Chinese battery manufacturer CATL.
The pills showed promise in combating the substances that lead to the harmful tangles and plaques in the brain that contribute to the disease.
Ghana’s approval of the R21 malaria vaccine — the first anywhere in the world — clears the way for children as young as five months to be protected against a disease that kills roughly 620,000 people every year, mostly young kids in Africa. Developed at Oxford’s Jenner Institute, R21 showed up to 80% effectiveness in early trials and is expected to cost just a couple of dollars per dose. The Serum Institute of India is preparing to produce up to 200 million doses a year, with a factory rising in Accra so supply stays close to home. After a century of scientific near-misses, an African regulator stepped forward and said: this one is ready.
A single dose of this radioimmunotherapy was found to eliminate tumor cells and extend the life of mice injected with cancerous cells for more than 221 days (the trial endpoint), compared to just 19 days in untreated control mice.
With the Swiss national railway network stretching beyond 2,000 miles of track, estimates place the amount of power generation at potentially beyond 1 terawatt hour or 2% of the entire gross annual consumption.
The new drug, called revumenib, has completely eliminated cancer in a third of the participants in a long-awaited clinical study from the University of Texas.
Called pulsed field ablation, the technique uses electrical pulses to create tiny holes in the membranes of heart muscle cells, causing the cells to die.
The drug, developed by researchers at the U.K.’s University of East Anglia, increases survival rates by 50% without the need for surgery or chemotherapy.
Gene therapy has cured 19-month-old Teddi Shaw of metachromatic leukodystrophy, making her the first NHS patient treated for this rare, fatal nervous system disease. After a single infusion of Libmeldy at Royal Manchester Children’s Hospital, she’s now running around, chattering away, and showing no signs of the illness that typically kills children before age eight. The treatment works by correcting a faulty gene in the child’s own stem cells, eliminating the disease at its root rather than managing it. Her family’s joy is tempered by grief — Teddi’s older sister was diagnosed too late for the therapy to help, fueling calls for newborn screening. It’s a glimpse of medicine’s next era: one-time cures for inherited conditions, if access and early detection can keep pace.
The new construction technique produces wind turbine towers 10 times faster while using up to 80% less manpower. Ultimately, this makes wind turbines much more affordable and cost-effective.